Laniquidar

DB12799InvestigationalSmall molecule

Laniquidar has been used in trials studying the treatment of Breast Cancer.

Chemical structure of Laniquidar
Formula / weight
C37H36N4O3 · 584.72 g/mol (avg)

Resolves to

Compound
UNIIK3FRN4DDOYCAS197509-46-9ChEMBLCHEMBL539378PubChem6450806
Structure
InChIKeyTULGGJGJQXESOO-UHFFFAOYSA-NSMILESCOC(=O)C1=CN=C2N1CCC1=CC=CC=C1C2=C1CCN(CCC2=CC=C(OCC3=CC=C4C=CC=CC4=N3)C=C2)CC1
Targets
P21439ABCB4
Transporters
P08183ABCB1

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
164Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Laniquidar, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In